VEGF-话题@MedSci - 梅斯（MedSci）

#VEGF#

104篇内容 | 3345人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1368519, encodeId=f336136851935, content=<a href='/topic/show?id=25aa1833e88' target=_blank style='color:#2F92EE;'>#VEGF#</a>, objectTitle=达伯舒®联合抗VEGF单抗用于一线HCC的研究完成首例患者给药, objectType=article, longId=161437, objectId=0fed16143ef7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0fed16143ef7, replyNumber=0, likeNumber=61, createdTime=2019-03-02, rootId=0, userName=fanweitanzhen, userId=80ca273, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0fed16143ef7, moduleTitle=达伯舒®联合抗VEGF单抗用于一线HCC的研究完成首例患者给药, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=0fed16143ef7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368518, encodeId=129f1368518c1, content=<a href='/topic/show?id=25aa1833e88' target=_blank style='color:#2F92EE;'>#VEGF#</a>, objectTitle=J Periodontol：健康和牙周疾病中龈沟液及唾液中HIF-1α, VEGF和TNF-α水平变化, objectType=article, longId=159083, objectId=8caf1590833e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8caf1590833e, replyNumber=0, likeNumber=89, createdTime=2019-01-29, rootId=0, userName=fanweitanzhen, userId=80ca273, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8caf1590833e, moduleTitle=J Periodontol：健康和牙周疾病中龈沟液及唾液中HIF-1α, VEGF和TNF-α水平变化, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=8caf1590833e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368517, encodeId=835a136851ea4, content=<a href='/topic/show?id=25aa1833e88' target=_blank style='color:#2F92EE;'>#VEGF#</a>, objectTitle=JCLA：VEGF基因CIC单倍型可能是突尼斯UBC发生发展的重要危险因素？, objectType=article, longId=158381, objectId=dd17158381f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dd17158381f0, replyNumber=0, likeNumber=59, createdTime=2019-01-20, rootId=0, userName=fanweitanzhen, userId=80ca273, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dd17158381f0, moduleTitle=JCLA：VEGF基因CIC单倍型可能是突尼斯UBC发生发展的重要危险因素？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=dd17158381f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368516, encodeId=51bd1368516d7, content=<a href='/topic/show?id=25aa1833e88' target=_blank style='color:#2F92EE;'>#VEGF#</a>, objectTitle=Gastroenterology：胆汁酸盐通过VEGF信号通路在非肿瘤性Barrett细胞中诱导上皮细胞向间充质细胞转化, objectType=article, longId=157439, objectId=259a15e43902, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=259a15e43902, replyNumber=0, likeNumber=67, createdTime=2019-01-08, rootId=0, userName=fanweitanzhen, userId=80ca273, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=259a15e43902, moduleTitle=Gastroenterology：胆汁酸盐通过VEGF信号通路在非肿瘤性Barrett细胞中诱导上皮细胞向间充质细胞转化, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=259a15e43902)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368515, encodeId=5f38136851581, content=<a href='/topic/show?id=25aa1833e88' target=_blank style='color:#2F92EE;'>#VEGF#</a>, objectTitle=DIABETOLOGIA：DPP-4抑制剂利格列汀抗血管生成作用是通过抑制氧诱导视网膜病变小鼠模型中VEGFR信号通路实现的？, objectType=article, longId=156533, objectId=8846156533e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8846156533e5, replyNumber=0, likeNumber=41, createdTime=2018-12-25, rootId=0, userName=fanweitanzhen, userId=80ca273, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8846156533e5, moduleTitle=DIABETOLOGIA：DPP-4抑制剂利格列汀抗血管生成作用是通过抑制氧诱导视网膜病变小鼠模型中VEGFR信号通路实现的？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=8846156533e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368514, encodeId=1e8613685141d, content=<a href='/topic/show?id=25aa1833e88' target=_blank style='color:#2F92EE;'>#VEGF#</a>, objectTitle=Int J Mol Sci：MicroRNA 210介导人类牙周韧带干细胞VEGF上调在3D羟基磷灰石陶瓷支架上培养, objectType=article, longId=156510, objectId=c9b315651040, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c9b315651040, replyNumber=0, likeNumber=68, createdTime=2018-12-25, rootId=0, userName=fanweitanzhen, userId=80ca273, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c9b315651040, moduleTitle=Int J Mol Sci：MicroRNA 210介导人类牙周韧带干细胞VEGF上调在3D羟基磷灰石陶瓷支架上培养, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c9b315651040)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368513, encodeId=6bd4136851340, content=<a href='/topic/show?id=25aa1833e88' target=_blank style='color:#2F92EE;'>#VEGF#</a>, objectTitle=Inflammation：VEGF，微血管密度和CD44可作为种植体周围病的标志物, objectType=article, longId=156327, objectId=4fc515632ea7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4fc515632ea7, replyNumber=0, likeNumber=85, createdTime=2018-12-22, rootId=0, userName=fanweitanzhen, userId=80ca273, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4fc515632ea7, moduleTitle=Inflammation：VEGF，微血管密度和CD44可作为种植体周围病的标志物, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=4fc515632ea7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368512, encodeId=8b12136851215, content=<a href='/topic/show?id=25aa1833e88' target=_blank style='color:#2F92EE;'>#VEGF#</a>, objectTitle=J Tissue Eng Regen Med：通过调节VEGF-A表达，Corin是软骨内骨化和骨发育的关键调节因子, objectType=article, longId=152611, objectId=3e7d1526117a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3e7d1526117a, replyNumber=0, likeNumber=55, createdTime=2018-11-03, rootId=0, userName=fanweitanzhen, userId=80ca273, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3e7d1526117a, moduleTitle=J Tissue Eng Regen Med：通过调节VEGF-A表达，Corin是软骨内骨化和骨发育的关键调节因子, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=3e7d1526117a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368511, encodeId=b4081368511c3, content=<a href='/topic/show?id=25aa1833e88' target=_blank style='color:#2F92EE;'>#VEGF#</a>, objectTitle=Biomed Res Int：nHAC/PLGA支架控释BMP-2和VEGF对成骨作用的协同作用, objectType=article, longId=152583, objectId=520915258325, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=520915258325, replyNumber=0, likeNumber=63, createdTime=2018-11-03, rootId=0, userName=fanweitanzhen, userId=80ca273, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=520915258325, moduleTitle=Biomed Res Int：nHAC/PLGA支架控释BMP-2和VEGF对成骨作用的协同作用, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=520915258325)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368510, encodeId=dd2213685100a, content=<a href='/topic/show?id=25aa1833e88' target=_blank style='color:#2F92EE;'>#VEGF#</a>, objectTitle=BJC：肿瘤浸润中性粒细胞不利于转移性结直肠癌的抗VEGF治疗, objectType=article, longId=152459, objectId=382a1524592e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=382a1524592e, replyNumber=0, likeNumber=62, createdTime=2018-11-02, rootId=0, userName=fanweitanzhen, userId=80ca273, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=382a1524592e, moduleTitle=BJC：肿瘤浸润中性粒细胞不利于转移性结直肠癌的抗VEGF治疗, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=382a1524592e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368509, encodeId=96d6136850943, content=<a href='/topic/show?id=25aa1833e88' target=_blank style='color:#2F92EE;'>#VEGF#</a>, objectTitle=JAHA：疑似或已知冠状动脉疾病患者VEGF-C水平与死亡率, objectType=article, longId=152002, objectId=c55d15200260, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c55d15200260, replyNumber=0, likeNumber=70, createdTime=2018-10-29, rootId=0, userName=fanweitanzhen, userId=80ca273, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c55d15200260, moduleTitle=JAHA：疑似或已知冠状动脉疾病患者VEGF-C水平与死亡率, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c55d15200260)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368508, encodeId=efc21368508ac, content=<a href='/topic/show?id=25aa1833e88' target=_blank style='color:#2F92EE;'>#VEGF#</a>, objectTitle=诺华申请将VEGF单抗Lucentis用于治疗早产儿视网膜病变, objectType=article, longId=149545, objectId=644a149545e1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=644a149545e1, replyNumber=0, likeNumber=54, createdTime=2018-09-26, rootId=0, userName=fanweitanzhen, userId=80ca273, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=644a149545e1, moduleTitle=诺华申请将VEGF单抗Lucentis用于治疗早产儿视网膜病变, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=644a149545e1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368507, encodeId=ac91136850e23, content=<a href='/topic/show?id=25aa1833e88' target=_blank style='color:#2F92EE;'>#VEGF#</a>, objectTitle=Celgene退出双特异性抗体navicixizumab (anti-DLL4/VEGF)的研发, objectType=article, longId=149481, objectId=279d149481fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=279d149481fd, replyNumber=0, likeNumber=60, createdTime=2018-09-25, rootId=0, userName=fanweitanzhen, userId=80ca273, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=279d149481fd, moduleTitle=Celgene退出双特异性抗体navicixizumab (anti-DLL4/VEGF)的研发, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=279d149481fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368506, encodeId=721e1368506a5, content=<a href='/topic/show?id=25aa1833e88' target=_blank style='color:#2F92EE;'>#VEGF#</a>, objectTitle=PLoS One：糖尿病性黄斑水肿患者房水中的细胞因子水平对抗VEGF治疗, objectType=article, longId=149260, objectId=e98c1492604b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e98c1492604b, replyNumber=0, likeNumber=97, createdTime=2018-09-22, rootId=0, userName=fanweitanzhen, userId=80ca273, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e98c1492604b, moduleTitle=PLoS One：糖尿病性黄斑水肿患者房水中的细胞因子水平对抗VEGF治疗, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e98c1492604b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368505, encodeId=207f136850558, content=<a href='/topic/show?id=25aa1833e88' target=_blank style='color:#2F92EE;'>#VEGF#</a>, objectTitle=CLIN CANCER RES：镭223联合VEGF靶向疗法治疗晚期肾细胞癌, objectType=article, longId=148296, objectId=cc7714829642, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cc7714829642, replyNumber=0, likeNumber=93, createdTime=2018-09-07, rootId=0, userName=fanweitanzhen, userId=80ca273, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cc7714829642, moduleTitle=CLIN CANCER RES：镭223联合VEGF靶向疗法治疗晚期肾细胞癌, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=cc7714829642)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368504, encodeId=0aae13685043e, content=<a href='/topic/show?id=25aa1833e88' target=_blank style='color:#2F92EE;'>#VEGF#</a>, objectTitle=PLos One：非小细胞肺癌中VEGFC/VEGFR3轴介导TGFβ1诱导的上皮-间质转化, objectType=article, longId=144456, objectId=870f1444563b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=870f1444563b, replyNumber=0, likeNumber=82, createdTime=2018-07-16, rootId=0, userName=fanweitanzhen, userId=80ca273, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=870f1444563b, moduleTitle=PLos One：非小细胞肺癌中VEGFC/VEGFR3轴介导TGFβ1诱导的上皮-间质转化, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=870f1444563b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368503, encodeId=dd431368503c2, content=<a href='/topic/show?id=25aa1833e88' target=_blank style='color:#2F92EE;'>#VEGF#</a>, objectTitle=PLOS ONE：鼻内递送VEGF帮助代偿性肺生长, objectType=article, longId=140389, objectId=5ed21403899b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5ed21403899b, replyNumber=0, likeNumber=58, createdTime=2018-06-10, rootId=0, userName=fanweitanzhen, userId=80ca273, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5ed21403899b, moduleTitle=PLOS ONE：鼻内递送VEGF帮助代偿性肺生长, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=5ed21403899b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368502, encodeId=c84013685023d, content=<a href='/topic/show?id=25aa1833e88' target=_blank style='color:#2F92EE;'>#VEGF#</a>, objectTitle=Brit J Cancer：转移性肾细胞癌免疫组合治疗后VEGFR TKI治疗效果研究, objectType=article, longId=139220, objectId=46ac139220d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=46ac139220d5, replyNumber=0, likeNumber=62, createdTime=2018-05-28, rootId=0, userName=fanweitanzhen, userId=80ca273, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=46ac139220d5, moduleTitle=Brit J Cancer：转移性肾细胞癌免疫组合治疗后VEGFR TKI治疗效果研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=46ac139220d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368501, encodeId=c1c013685012f, content=<a href='/topic/show?id=25aa1833e88' target=_blank style='color:#2F92EE;'>#VEGF#</a>, objectTitle=Sci Signal：突破常识！VEGF不仅促进肿瘤血管生长，对乳腺癌细胞本身也有促进作用, objectType=article, longId=137492, objectId=c65f13e492b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c65f13e492b7, replyNumber=0, likeNumber=111, createdTime=2018-05-09, rootId=0, userName=fanweitanzhen, userId=80ca273, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c65f13e492b7, moduleTitle=Sci Signal：突破常识！VEGF不仅促进肿瘤血管生长，对乳腺癌细胞本身也有促进作用, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c65f13e492b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368500, encodeId=0b1c13685005a, content=<a href='/topic/show?id=25aa1833e88' target=_blank style='color:#2F92EE;'>#VEGF#</a>, objectTitle=Medicine：血浆中的VEGF水平与2型糖尿病中的代谢控制、炎症和微血管并发症有关, objectType=article, longId=137478, objectId=a5ef13e4784d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a5ef13e4784d, replyNumber=0, likeNumber=78, createdTime=2018-05-09, rootId=0, userName=fanweitanzhen, userId=80ca273, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a5ef13e4784d, moduleTitle=Medicine：血浆中的VEGF水平与2型糖尿病中的代谢控制、炎症和微血管并发症有关, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a5ef13e4784d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

VEGF

2020-05-29

fanweitanzhen (审核中...)

前往app查看评论内容

#VEGF#

达伯舒®联合抗VEGF单抗用于一线HCC的研究完成首例患者给药

2019-03-02

fanweitanzhen (审核中...)

前往app查看评论内容

#VEGF#

J Periodontol：健康和牙周疾病中龈沟液及唾液中HIF-1α, VEGF和TNF-α水平变化

2019-01-29

fanweitanzhen (审核中...)

前往app查看评论内容

#VEGF#

JCLA：VEGF基因CIC单倍型可能是突尼斯UBC发生发展的重要危险因素？

2019-01-20

fanweitanzhen (审核中...)

前往app查看评论内容

#VEGF#

Gastroenterology：胆汁酸盐通过VEGF信号通路在非肿瘤性Barrett细胞中诱导上皮细胞向间充质细胞转化

2019-01-08

fanweitanzhen (审核中...)

前往app查看评论内容

#VEGF#

DIABETOLOGIA：DPP-4抑制剂利格列汀抗血管生成作用是通过抑制氧诱导视网膜病变小鼠模型中VEGFR信号通路实现的？

2018-12-25

fanweitanzhen (审核中...)

前往app查看评论内容

#VEGF#

Int J Mol Sci：MicroRNA 210介导人类牙周韧带干细胞VEGF上调在3D羟基磷灰石陶瓷支架上培养

2018-12-25

fanweitanzhen (审核中...)

前往app查看评论内容

#VEGF#

Inflammation：VEGF，微血管密度和CD44可作为种植体周围病的标志物

2018-12-22

fanweitanzhen (审核中...)

前往app查看评论内容

#VEGF#

J Tissue Eng Regen Med：通过调节VEGF-A表达，Corin是软骨内骨化和骨发育的关键调节因子

2018-11-03

fanweitanzhen (审核中...)

前往app查看评论内容

#VEGF#

Biomed Res Int：nHAC/PLGA支架控释BMP-2和VEGF对成骨作用的协同作用

2018-11-03

fanweitanzhen (审核中...)

前往app查看评论内容

#VEGF#

BJC：肿瘤浸润中性粒细胞不利于转移性结直肠癌的抗VEGF治疗

2018-11-02

fanweitanzhen (审核中...)

前往app查看评论内容

#VEGF#

JAHA：疑似或已知冠状动脉疾病患者VEGF-C水平与死亡率

2018-10-29

fanweitanzhen (审核中...)

前往app查看评论内容

#VEGF#

诺华申请将VEGF单抗Lucentis用于治疗早产儿视网膜病变

2018-09-26

fanweitanzhen (审核中...)

前往app查看评论内容

#VEGF#

Celgene退出双特异性抗体navicixizumab (anti-DLL4/VEGF)的研发

2018-09-25

fanweitanzhen (审核中...)

前往app查看评论内容

#VEGF#

PLoS One：糖尿病性黄斑水肿患者房水中的细胞因子水平对抗VEGF治疗

2018-09-22

fanweitanzhen (审核中...)

前往app查看评论内容

#VEGF#

CLIN CANCER RES：镭223联合VEGF靶向疗法治疗晚期肾细胞癌

2018-09-07

fanweitanzhen (审核中...)

前往app查看评论内容

#VEGF#

PLos One：非小细胞肺癌中VEGFC/VEGFR3轴介导TGFβ1诱导的上皮-间质转化

2018-07-16

fanweitanzhen (审核中...)

前往app查看评论内容

#VEGF#

PLOS ONE：鼻内递送VEGF帮助代偿性肺生长

2018-06-10

fanweitanzhen (审核中...)

前往app查看评论内容

#VEGF#

Brit J Cancer：转移性肾细胞癌免疫组合治疗后VEGFR TKI治疗效果研究

2018-05-28

fanweitanzhen (审核中...)

前往app查看评论内容

#VEGF#

Sci Signal：突破常识！VEGF不仅促进肿瘤血管生长，对乳腺癌细胞本身也有促进作用

2018-05-09

fanweitanzhen (审核中...)

前往app查看评论内容

#VEGF#

Medicine：血浆中的VEGF水平与2型糖尿病中的代谢控制、炎症和微血管并发症有关

2018-05-09

科室
- - 订阅+
  - 更多科室
工具
服务